Organs-on-Chips Market by Type of Product (organ based and disease based), Type of Organ (single organ based and multi organ based), Type of Single Organ based Model (liver, lung, brain, heart, intestine, kidney and other organs), Type of Material of Cons
Description
ORGANS-ON-CHIPS MARKET
As per Roots Analysis, the global organ on a chip market size is estimated to grow from USD 77 million in the current year to USD 944 million by 2035, at a CAGR of 25. 6% during the forecast period, till 2035.
The opportunity for organ on a chip market has been distributed across the following segments:
Type of Product
Organ based
Disease based
Type of Organ
Single organ based
Multi organ based
Type of Single Organ based Model
Liver
Lung
Brain
Heart
Intestine
Kidney
Other organs
Type of Material of Construction
Polydimethylsiloxane
Other polymer
Glass
Others
Purpose
Research
Therapeutic
Application Area
Drug discovery / toxicity testing
Cancer research
Stem cell research
Tissue engineering / regenerative medicine
Others
End User
Pharmaceutical and biotech companies
Academic and research players
Cosmetic industry players
Other end users
Key Geographical Regions
North America
Europe
Asia-Pacific
Latin America
Middle East and North Africa
Leading Players
ORGANS-ON-CHIPS MARKET: GROWTH AND TRENDS
Organ-on-chips are the miniature copies of the vital human organs (such as, liver, lungs, kidneys, intestines, and other vital organs) that have been developed by researchers / start-ups for several medical research and therapy development purposes. These miniature copies are remodeled using microfabrication techniques and have chambers with live cells (continually perfused with cell culture media) that mimic the physio-chemical microenvironment of tissues in the human body.
According to research, 1 out of 1,000 drug candidates proceed to clinical trials post preclinical testing. Of these, 90% of the candidates fail to enter the market, primarily due to the lack of efficacy / unforeseen toxicity observed during the clinical trials and the limitation of animal based preclinical models to precisely predict human responses (owing to the difficulty in mimicking the exact and intricate human biology / mechanisms). Therefore, to address these issues / limitations and in an effort to reduce the healthcare burden due to drug failures, several researchers are striving to adopt alternative testing methods, such as organ-on-a-chip technology. Currently, 75 integrated organ-on-chip technologies and models are available in the market, offering distinct advantages over the traditional cell culture and animal-based testing methods, such as enhanced accuracy in predicting physiological responses like humans, high in vivo replicability, reduced trial costs and dependency on animal models.
Driven by these benefits and the interest of industry stakeholders, the adoption of these advanced models in the R&D of novel drugs and ADME toxicology testing is steadily increasing and is anticipated to improve the success rates of drugs in clinical trials. Moreover, as the global organ-on-chip market matures, the development and application of these models will expand, driving innovation and positioning the market for steady growth in the forthcoming years.
ORGANS-ON-CHIPS MARKET: KEY INSIGHTS
The report delves into the current state of the organs-on-chips market and identifies potential growth opportunities within the industry. Some key findings from the report include:
1. More than 70 organ-on-chip technologies and models have been launched / approved or are currently under development; the market landscape features the presence of both established players and new entrants.
2. Majority of the technologies and models support both organ-based and disease-based applications; of these, 98% of the technologies / models are preferred for drug discovery and toxicity testing studies.
3. Presently, 25 players (established players as well as start-ups) claim to provide organ-on-chips and plates; more than 60% of these firms have been established post-2013.
4. Over 50% of organ-on-chips products are microfluidic plates; interestingly, majority of these chips and plates are constructed from polymers due to their flexibility and moldability.
5. More than 600 patents related to organ-on-chip have been filed / granted by industry and non-industry stakeholders, indicating a growing intellectual capital in the domain.
6. The growing interest of stakeholders is evident from the increasing partnership activities; technology / product utilization agreements emerged as the most prevalent partnership model adopted by organ-on-chip providers.
7. Close to 350 grants have been awarded for ongoing research and development efforts for organ-on-chip products and technologies; National Center for Advancing Translational Sciences has awarded the maximum grant amount.
8. Since 2017, over USD 350 million have been invested by several investors across various funding rounds, thereby presenting lucrative growth opportunities within this emerging segment.
9. In recent years, stakeholders have established strong brand positions to cater to the increasing demand for organ-on-chips; several players have introduced efficient, easy to use, and advanced products.
10. The growing demand for animal free testing and advancements in microfluidics has emerged as key driving factors supporting the rapid evolution of the organ-on-chip market.
11. Owing to the ability of organ-on-chips to provide animal free testing models and substantially reduce the costs associated with drug testing, the market is anticipated to witness a growth of 25. 6% over the next decade.
ORGANS-ON-CHIPS MARKET: KEY SEGMENTS
Disease-based Model is the Fastest Growing Segment of the Organs-on-Chips Market
Based on the type of product, the global market for organs-on-chips is segmented into organ based and disease-based models. Currently, majority share of the organ-on-chip market is captured by organ-based models. It is worth mentioning that the disease-based model segment is likely to grow at a higher CAGR (around 27%) in the coming years.
Organ-on-Chip Products Supporting Single Organ-based Models are Likely to Dominate the Organs-on-Chips Market During the Forecast Period
Based on the type of organ, the global organs-on-chips market is distributed across single organ and multi organ-based models. Whilst the organs-on-chip products supporting single organ-based models hold the majority of the market share, it is worth noting that organ-on-chip market for multi-organ-based models is likely to grow at a relatively higher CAGR during the forecast period. This can be attributed to the capability of multi-organ models to efficiently track metabolic pathways and assess organ-organ crosstalk.
Liver-on-a-Chip Models are Likely to Hold the Largest Share of the Organs-on-Chips Market During the Forecast Period
Based on the type of single organ-based model, the global market is segmented into liver, lung, brain, heart, intestine, kidney and other organs-based models. Currently, the liver-on-a-chip models are likely to dominate and drive the overall market growth. It is worth noting that the lung, brain, and heart-on-a-chip models are likely to flourish during the forecast period. This can be attributed to the ability of these models to mimic the exact and intricate human biology / mechanisms.
Organs-on-Chips Market for Other Polymers is Likely to Grow at a Relatively Faster Pace During the Forecast Period
Based on the type of material, the global market value is segmented across polydimethylsiloxane (PDMS), other polymers, glass and other materials. Notably, owing to the high flexibility, transparency and gas permeability of PDMS, it is likely to dominate the organs-on-chips market during the forecast period.
Organs-On-Chips Market for Therapeutic Purposes is Likely to Grow at a Higher CAGR During the Forecast Period
Based on purpose, the global market is segmented into research and therapeutic purposes. Currently, organ-on-chips focussed on research purposes hold a larger share of the overall market. However, this trend is likely to change during the forecast period due to the expanding application of such chips across multiple therapeutic areas.
By Application Area, Organs-on-Chips for Cancer Research are Likely to Dominate the Market During the Forecast Period
Based on the application area, the global market for organs on chips is distributed across drug discovery and toxicity testing, cancer research, stem cell research and tissue engineering and regenerative medicines. Whilst the organs-on-chip models and plates for cancer research will be the primary drivers of the overall market, it is worth highlighting that the market for organ-on-chips models used in stem cell research and tissue engineering is likely to grow at a relatively higher CAGR.
Currently, Pharmaceutical and Biotech Companies Hold the Largest Share of the Organs-On-Chips Market
Based on end users, the global market is segmented into pharmaceutical and biotech companies, academic and research players, cosmetic industry players, and other end users. Currently, pharmaceutical and biotech companies hold the largest market share. However, organ-on-chip market for cosmetic industry is expected to witness substantial growth in the coming years.
North America Accounts for the Largest Share of the Market
Based on key geographical regions, the market is segmented into North America, Europe, Asia-Pacific, Latin America and Middle East and North Africa. In the current scenario, North America is likely to capture the largest market share. However, owing to the ban on animal model testing in European countries, the organ-on-chip market in Europe is expected to grow at a higher CAGR during the forecast period.
Example Players in the Organs-on-Chips Market
4DCell
Aim biotech
Beonchip
Bi/ond
CN BIO
Emulate
InSphero
Jiksak Bioengineering
Kirkstall
Lena Biosciences
Merck Millipore
MesoBio Tech
MicroBrain Biotech
Mimetas
Numa Biosciences
Qureator
SynVivo
TissUse
Visikol
Xona microfluidics
Primary Research Overview
The opinions and insights presented in this study were influenced by discussions conducted with multiple stakeholders. The research report features detailed transcripts of interviews held with the following industry stakeholders:
Chief Executive Officer, Small Company, US
Chief Executive Officer, Mid-sized Company, France
Chief Executive Officer, Small Company, South Korea
Chief Executive Officer, Small Company, Italy
Chief Executive Officer, Small Company, Scotland
Chief Technology Officer, Mid-sized Company, The Netherlands
Chief Business Development Officer, Mid-sized Company, France
President, Mid-sized Company, US
ORGANS-ON-CHIPS MARKET: RESEARCH COVERAGE
The report on Organs-on-Chips Market features insights on various sections, including:
Market Sizing and Opportunity Analysis: An in-depth analysis of the organ-on-chip market, focusing on key market segments, including [A] type of product, [B] type of organ, [C] type of single organ-based model, [D] type of material of construction, [E] purpose, [F] application area, [G] end user, [H] key geographical regions and [I] leading players.
Market Impact Analysis: A thorough analysis of various factors, such as drivers, restraints, opportunities, and existing challenges that are likely to impact market growth.
Organ-on-Chip Technologies and Models Market Landscape: A comprehensive evaluation of organ-on-chips and plates, based on several relevant parameters, such as [A] type of model, [B] compatible organ, and [C] application area.
Organ-on-Chip Technologies and Models Developer Landscape: The report features a list of players engaged in the development of organ-on-chips and plates offered, along with analyses based on [A] year of establishment, [B] company size, [C] location of headquarters and [D] leading technology providers.
Organ-on-Chip and Plates Market Landscape: A comprehensive evaluation of organ-on-chips and plates, based on several relevant parameters, such as [A] type of product, [B] type of model, [C] compatible organs, [D] application area, [E] material of construction, [F] type of polymer and [G] status of development.
Organ-on-Chip and Plates Developer Landscape: The report features a list of players engaged in the development of organ-on-chips and plates offered, along with analyses based on [A] year of establishment, [B] company size, [C] location of headquarters and [D] leading chips and plate providers.
Company Profiles: In-depth profiles of key industry players offering big data analytics solutions across various geographies, focusing on [A] company overviews, [B] financial information (if available), [C] organ-on-chip portfolio, [D] recent developments and [E] an informed future outlook.
Patents Analysis: An in-depth analysis of patents filed / granted till date in the organ-on-chip domain, based on various relevant parameters, such as [A] type of patent, [B] publication year, [C] application year, [D] patent jurisdiction, [E] CPC symbols, [F] type of applicant, [G] patent age, [H] leading inventors, [I] leading industry and non-industry players, [J] patent benchmarking, and [K] patent valuation analysis.
Brand Positioning Analysis: A detailed analysis of the [A] organ-on-chip technology and model providers and [B] organ-on-chips and plate providers, highlighting the current perceptions regarding their proprietary technologies, models, chips and plates by taking into consideration several relevant aspects, such as portfolio strength, portfolio diversity, years of experience, and company size.
Academic Grants Analysis: A comprehensive assessment of grants that have been awarded to research institutes in the organ-on-chip domain, based on various relevant parameters, such as [A] year of award, [B] amount awarded, [C] administering institute center, [D] support period, [E] type of grant application, [F] purpose of grant, [G] activity code, [H] emerging focus area, [I] study section involved, [J] popular NIH departments, [K] type of recipient organization, [L] leading recipient organizations and [M] location of recipient organization.
Partnerships and Collaborations: An insightful analysis of the deals inked by stakeholders in organs-on-chips market, based on several parameters, such as [A] year of partnership, [B] type of partnership, [C] type of organ, [D] geographical regions, [E] purpose of partnership, [F] most active players and [G] geographical distribution of partnership activity.
Funding and Investment Analysis: An in-depth analysis of the fundings raised by organ on a chip companies, based on relevant parameters, such as [A] year of funding, [B] type of funding, [C] amount invested (USD million), [D] purpose of funding, [E] associated organ / system, [F] therapeutic area, [G] geographical area, and [H] most active players.
Case Study: A detailed assessment of scaffold-free 3D cell culture products, featuring a list of more than 60 products that are being used for research and pharmaceutical testing, based on a number of relevant parameters, such as [A] status of development, [B] type of system, [C] type of product and [D] material used for fabrication.
KEY QUESTIONS ANSWERED IN THIS REPORT
How many companies are currently engaged in this market?
Which are the leading companies in this market?
What factors are likely to influence the evolution of this market?
What is the current and future market size?
What is the CAGR of this market?
How is the current and future market opportunity likely to be distributed across key market segments?
What kind of partnership models are commonly adopted by industry stakeholders?
What is the ongoing investment trend in this market?
What is the patent filing activity trend in the market?
REASONS TO BUY THIS REPORT
The report provides a comprehensive market analysis, offering detailed revenue projections of the overall market and its specific sub-segments. This information is valuable to both established market leaders and emerging entrants.
Stakeholders can leverage the report to gain a deeper understanding of the competitive dynamics within the market. By analyzing the competitive landscape, businesses can make informed decisions to optimize their market positioning and develop effective go-to-market strategies.
The report offers stakeholders a comprehensive overview of the market, including key drivers, barriers, opportunities, and challenges. This information empowers stakeholders to stay abreast of market trends and make data-driven decisions to capitalize on growth prospects.
ADDITIONAL BENEFITS
Complimentary PPT Insights Packs
Complimentary Excel Data Packs for all Analytical Modules in the Report
As per Roots Analysis, the global organ on a chip market size is estimated to grow from USD 77 million in the current year to USD 944 million by 2035, at a CAGR of 25. 6% during the forecast period, till 2035.
The opportunity for organ on a chip market has been distributed across the following segments:
Type of Product
Organ based
Disease based
Type of Organ
Single organ based
Multi organ based
Type of Single Organ based Model
Liver
Lung
Brain
Heart
Intestine
Kidney
Other organs
Type of Material of Construction
Polydimethylsiloxane
Other polymer
Glass
Others
Purpose
Research
Therapeutic
Application Area
Drug discovery / toxicity testing
Cancer research
Stem cell research
Tissue engineering / regenerative medicine
Others
End User
Pharmaceutical and biotech companies
Academic and research players
Cosmetic industry players
Other end users
Key Geographical Regions
North America
Europe
Asia-Pacific
Latin America
Middle East and North Africa
Leading Players
ORGANS-ON-CHIPS MARKET: GROWTH AND TRENDS
Organ-on-chips are the miniature copies of the vital human organs (such as, liver, lungs, kidneys, intestines, and other vital organs) that have been developed by researchers / start-ups for several medical research and therapy development purposes. These miniature copies are remodeled using microfabrication techniques and have chambers with live cells (continually perfused with cell culture media) that mimic the physio-chemical microenvironment of tissues in the human body.
According to research, 1 out of 1,000 drug candidates proceed to clinical trials post preclinical testing. Of these, 90% of the candidates fail to enter the market, primarily due to the lack of efficacy / unforeseen toxicity observed during the clinical trials and the limitation of animal based preclinical models to precisely predict human responses (owing to the difficulty in mimicking the exact and intricate human biology / mechanisms). Therefore, to address these issues / limitations and in an effort to reduce the healthcare burden due to drug failures, several researchers are striving to adopt alternative testing methods, such as organ-on-a-chip technology. Currently, 75 integrated organ-on-chip technologies and models are available in the market, offering distinct advantages over the traditional cell culture and animal-based testing methods, such as enhanced accuracy in predicting physiological responses like humans, high in vivo replicability, reduced trial costs and dependency on animal models.
Driven by these benefits and the interest of industry stakeholders, the adoption of these advanced models in the R&D of novel drugs and ADME toxicology testing is steadily increasing and is anticipated to improve the success rates of drugs in clinical trials. Moreover, as the global organ-on-chip market matures, the development and application of these models will expand, driving innovation and positioning the market for steady growth in the forthcoming years.
ORGANS-ON-CHIPS MARKET: KEY INSIGHTS
The report delves into the current state of the organs-on-chips market and identifies potential growth opportunities within the industry. Some key findings from the report include:
1. More than 70 organ-on-chip technologies and models have been launched / approved or are currently under development; the market landscape features the presence of both established players and new entrants.
2. Majority of the technologies and models support both organ-based and disease-based applications; of these, 98% of the technologies / models are preferred for drug discovery and toxicity testing studies.
3. Presently, 25 players (established players as well as start-ups) claim to provide organ-on-chips and plates; more than 60% of these firms have been established post-2013.
4. Over 50% of organ-on-chips products are microfluidic plates; interestingly, majority of these chips and plates are constructed from polymers due to their flexibility and moldability.
5. More than 600 patents related to organ-on-chip have been filed / granted by industry and non-industry stakeholders, indicating a growing intellectual capital in the domain.
6. The growing interest of stakeholders is evident from the increasing partnership activities; technology / product utilization agreements emerged as the most prevalent partnership model adopted by organ-on-chip providers.
7. Close to 350 grants have been awarded for ongoing research and development efforts for organ-on-chip products and technologies; National Center for Advancing Translational Sciences has awarded the maximum grant amount.
8. Since 2017, over USD 350 million have been invested by several investors across various funding rounds, thereby presenting lucrative growth opportunities within this emerging segment.
9. In recent years, stakeholders have established strong brand positions to cater to the increasing demand for organ-on-chips; several players have introduced efficient, easy to use, and advanced products.
10. The growing demand for animal free testing and advancements in microfluidics has emerged as key driving factors supporting the rapid evolution of the organ-on-chip market.
11. Owing to the ability of organ-on-chips to provide animal free testing models and substantially reduce the costs associated with drug testing, the market is anticipated to witness a growth of 25. 6% over the next decade.
ORGANS-ON-CHIPS MARKET: KEY SEGMENTS
Disease-based Model is the Fastest Growing Segment of the Organs-on-Chips Market
Based on the type of product, the global market for organs-on-chips is segmented into organ based and disease-based models. Currently, majority share of the organ-on-chip market is captured by organ-based models. It is worth mentioning that the disease-based model segment is likely to grow at a higher CAGR (around 27%) in the coming years.
Organ-on-Chip Products Supporting Single Organ-based Models are Likely to Dominate the Organs-on-Chips Market During the Forecast Period
Based on the type of organ, the global organs-on-chips market is distributed across single organ and multi organ-based models. Whilst the organs-on-chip products supporting single organ-based models hold the majority of the market share, it is worth noting that organ-on-chip market for multi-organ-based models is likely to grow at a relatively higher CAGR during the forecast period. This can be attributed to the capability of multi-organ models to efficiently track metabolic pathways and assess organ-organ crosstalk.
Liver-on-a-Chip Models are Likely to Hold the Largest Share of the Organs-on-Chips Market During the Forecast Period
Based on the type of single organ-based model, the global market is segmented into liver, lung, brain, heart, intestine, kidney and other organs-based models. Currently, the liver-on-a-chip models are likely to dominate and drive the overall market growth. It is worth noting that the lung, brain, and heart-on-a-chip models are likely to flourish during the forecast period. This can be attributed to the ability of these models to mimic the exact and intricate human biology / mechanisms.
Organs-on-Chips Market for Other Polymers is Likely to Grow at a Relatively Faster Pace During the Forecast Period
Based on the type of material, the global market value is segmented across polydimethylsiloxane (PDMS), other polymers, glass and other materials. Notably, owing to the high flexibility, transparency and gas permeability of PDMS, it is likely to dominate the organs-on-chips market during the forecast period.
Organs-On-Chips Market for Therapeutic Purposes is Likely to Grow at a Higher CAGR During the Forecast Period
Based on purpose, the global market is segmented into research and therapeutic purposes. Currently, organ-on-chips focussed on research purposes hold a larger share of the overall market. However, this trend is likely to change during the forecast period due to the expanding application of such chips across multiple therapeutic areas.
By Application Area, Organs-on-Chips for Cancer Research are Likely to Dominate the Market During the Forecast Period
Based on the application area, the global market for organs on chips is distributed across drug discovery and toxicity testing, cancer research, stem cell research and tissue engineering and regenerative medicines. Whilst the organs-on-chip models and plates for cancer research will be the primary drivers of the overall market, it is worth highlighting that the market for organ-on-chips models used in stem cell research and tissue engineering is likely to grow at a relatively higher CAGR.
Currently, Pharmaceutical and Biotech Companies Hold the Largest Share of the Organs-On-Chips Market
Based on end users, the global market is segmented into pharmaceutical and biotech companies, academic and research players, cosmetic industry players, and other end users. Currently, pharmaceutical and biotech companies hold the largest market share. However, organ-on-chip market for cosmetic industry is expected to witness substantial growth in the coming years.
North America Accounts for the Largest Share of the Market
Based on key geographical regions, the market is segmented into North America, Europe, Asia-Pacific, Latin America and Middle East and North Africa. In the current scenario, North America is likely to capture the largest market share. However, owing to the ban on animal model testing in European countries, the organ-on-chip market in Europe is expected to grow at a higher CAGR during the forecast period.
Example Players in the Organs-on-Chips Market
4DCell
Aim biotech
Beonchip
Bi/ond
CN BIO
Emulate
InSphero
Jiksak Bioengineering
Kirkstall
Lena Biosciences
Merck Millipore
MesoBio Tech
MicroBrain Biotech
Mimetas
Numa Biosciences
Qureator
SynVivo
TissUse
Visikol
Xona microfluidics
Primary Research Overview
The opinions and insights presented in this study were influenced by discussions conducted with multiple stakeholders. The research report features detailed transcripts of interviews held with the following industry stakeholders:
Chief Executive Officer, Small Company, US
Chief Executive Officer, Mid-sized Company, France
Chief Executive Officer, Small Company, South Korea
Chief Executive Officer, Small Company, Italy
Chief Executive Officer, Small Company, Scotland
Chief Technology Officer, Mid-sized Company, The Netherlands
Chief Business Development Officer, Mid-sized Company, France
President, Mid-sized Company, US
ORGANS-ON-CHIPS MARKET: RESEARCH COVERAGE
The report on Organs-on-Chips Market features insights on various sections, including:
Market Sizing and Opportunity Analysis: An in-depth analysis of the organ-on-chip market, focusing on key market segments, including [A] type of product, [B] type of organ, [C] type of single organ-based model, [D] type of material of construction, [E] purpose, [F] application area, [G] end user, [H] key geographical regions and [I] leading players.
Market Impact Analysis: A thorough analysis of various factors, such as drivers, restraints, opportunities, and existing challenges that are likely to impact market growth.
Organ-on-Chip Technologies and Models Market Landscape: A comprehensive evaluation of organ-on-chips and plates, based on several relevant parameters, such as [A] type of model, [B] compatible organ, and [C] application area.
Organ-on-Chip Technologies and Models Developer Landscape: The report features a list of players engaged in the development of organ-on-chips and plates offered, along with analyses based on [A] year of establishment, [B] company size, [C] location of headquarters and [D] leading technology providers.
Organ-on-Chip and Plates Market Landscape: A comprehensive evaluation of organ-on-chips and plates, based on several relevant parameters, such as [A] type of product, [B] type of model, [C] compatible organs, [D] application area, [E] material of construction, [F] type of polymer and [G] status of development.
Organ-on-Chip and Plates Developer Landscape: The report features a list of players engaged in the development of organ-on-chips and plates offered, along with analyses based on [A] year of establishment, [B] company size, [C] location of headquarters and [D] leading chips and plate providers.
Company Profiles: In-depth profiles of key industry players offering big data analytics solutions across various geographies, focusing on [A] company overviews, [B] financial information (if available), [C] organ-on-chip portfolio, [D] recent developments and [E] an informed future outlook.
Patents Analysis: An in-depth analysis of patents filed / granted till date in the organ-on-chip domain, based on various relevant parameters, such as [A] type of patent, [B] publication year, [C] application year, [D] patent jurisdiction, [E] CPC symbols, [F] type of applicant, [G] patent age, [H] leading inventors, [I] leading industry and non-industry players, [J] patent benchmarking, and [K] patent valuation analysis.
Brand Positioning Analysis: A detailed analysis of the [A] organ-on-chip technology and model providers and [B] organ-on-chips and plate providers, highlighting the current perceptions regarding their proprietary technologies, models, chips and plates by taking into consideration several relevant aspects, such as portfolio strength, portfolio diversity, years of experience, and company size.
Academic Grants Analysis: A comprehensive assessment of grants that have been awarded to research institutes in the organ-on-chip domain, based on various relevant parameters, such as [A] year of award, [B] amount awarded, [C] administering institute center, [D] support period, [E] type of grant application, [F] purpose of grant, [G] activity code, [H] emerging focus area, [I] study section involved, [J] popular NIH departments, [K] type of recipient organization, [L] leading recipient organizations and [M] location of recipient organization.
Partnerships and Collaborations: An insightful analysis of the deals inked by stakeholders in organs-on-chips market, based on several parameters, such as [A] year of partnership, [B] type of partnership, [C] type of organ, [D] geographical regions, [E] purpose of partnership, [F] most active players and [G] geographical distribution of partnership activity.
Funding and Investment Analysis: An in-depth analysis of the fundings raised by organ on a chip companies, based on relevant parameters, such as [A] year of funding, [B] type of funding, [C] amount invested (USD million), [D] purpose of funding, [E] associated organ / system, [F] therapeutic area, [G] geographical area, and [H] most active players.
Case Study: A detailed assessment of scaffold-free 3D cell culture products, featuring a list of more than 60 products that are being used for research and pharmaceutical testing, based on a number of relevant parameters, such as [A] status of development, [B] type of system, [C] type of product and [D] material used for fabrication.
KEY QUESTIONS ANSWERED IN THIS REPORT
How many companies are currently engaged in this market?
Which are the leading companies in this market?
What factors are likely to influence the evolution of this market?
What is the current and future market size?
What is the CAGR of this market?
How is the current and future market opportunity likely to be distributed across key market segments?
What kind of partnership models are commonly adopted by industry stakeholders?
What is the ongoing investment trend in this market?
What is the patent filing activity trend in the market?
REASONS TO BUY THIS REPORT
The report provides a comprehensive market analysis, offering detailed revenue projections of the overall market and its specific sub-segments. This information is valuable to both established market leaders and emerging entrants.
Stakeholders can leverage the report to gain a deeper understanding of the competitive dynamics within the market. By analyzing the competitive landscape, businesses can make informed decisions to optimize their market positioning and develop effective go-to-market strategies.
The report offers stakeholders a comprehensive overview of the market, including key drivers, barriers, opportunities, and challenges. This information empowers stakeholders to stay abreast of market trends and make data-driven decisions to capitalize on growth prospects.
ADDITIONAL BENEFITS
Complimentary PPT Insights Packs
Complimentary Excel Data Packs for all Analytical Modules in the Report
Table of Contents
218 Pages
- 1. Preface
- 1.1. Introduction
- 1.2. Market Share Insights
- 1.3. Key Market Insights
- 1.4. Report Coverage
- 1.5. Key Questions Answered
- 1.6. Chapter Outlines
- 2. Research Methodology
- 2.1. Chapter Overview
- 2.2. Research Assumptions
- 2.2.1. Market Landscape And Market Trends
- 2.2.2. Market Forecast And Opportunity Analysis
- 2.2.3. Comparative Analysis
- 2.3. Database Building
- 2.3.1. Data Collection
- 2.3.2. Data Validation
- 2.3.3. Data Analysis
- 2.4. Project Methodology
- 2.4.1. Secondary Research
- 2.4.1.1. Annual Reports
- 2.4.1.2. Academic Research Papers
- 2.4.1.3. Company Websites
- 2.4.1.4. Investor Presentations
- 2.4.1.5. Regulatory Filings
- 2.4.1.6. White Papers
- 2.4.1.7. Industry Publications
- 2.4.1.8. Conferences And Seminars
- 2.4.1.9. Government Portals
- 2.4.1.10. Media And Press Releases
- 2.4.1.11. Newsletters
- 2.4.1.12. Industry Databases
- 2.4.1.13. Roots Proprietary Databases
- 2.4.1.14. Paid Databases And Sources
- 2.4.1.15. Social Media Portals
- 2.4.1.16. Other Secondary Sources
- 2.4.2. Primary Research
- 2.4.2.1. Types Of Primary Research
- 2.4.2.1.1. Qualitative Research
- 2.4.2.1.2. Quantitative Research
- 2.4.2.1.3. Hybrid Approach
- 2.4.2.2. Advantages Of Primary Research
- 2.4.2.3. Techniques For Primary Research
- 2.4.2.3.1. Interviews
- 2.4.2.3.2. Surveys
- 2.4.2.3.3. Focus Groups
- 2.4.2.3.4. Observational Research
- 2.4.2.3.5. Social Media Interactions
- 2.4.2.4. Key Opinion Leaders Considered In Primary Research
- 2.4.2.4.1. Company Executives (Cxos)
- 2.4.2.4.2. Board Of Directors
- 2.4.2.4.3. Company Presidents And Vice Presidents
- 2.4.2.4.4. Research And Development Heads
- 2.4.2.4.5. Technical Experts
- 2.4.2.4.6. Subject Matter Experts
- 2.4.2.4.7. Scientists
- 2.4.2.4.8. Doctors And Other Healthcare Providers
- 2.4.2.5. Ethics And Integrity
- 2.4.2.5.1. Research Ethics
- 2.4.2.5.2. Data Integrity
- 2.4.3. Analytical Tools And Databases
- 3. Market Dynamics
- 3.1. Chapter Overview
- 3.2. Forecast Methodology
- 3.2.1. Top-down Approach
- 3.2.2. Bottom-up Approach
- 3.2.3. Hybrid Approach
- 3.3. Market Assessment Framework
- 3.3.1. Total Addressable Market (Tam)
- 3.3.2. Serviceable Addressable Market (Sam)
- 3.3.3. Serviceable Obtainable Market (Som)
- 3.3.4. Currently Acquired Market (Cam)
- 3.4. Forecasting Tools And Techniques
- 3.4.1. Qualitative Forecasting
- 3.4.2. Correlation
- 3.4.3. Regression
- 3.4.4. Extrapolation
- 3.4.5. Convergence
- 3.4.6. Sensitivity Analysis
- 3.4.7. Scenario Planning
- 3.4.8. Data Visualization
- 3.4.9. Time Series Analysis
- 3.4.10. Forecast Error Analysis
- 3.5. Key Considerations
- 3.5.1. Demographics
- 3.5.2. Government Regulations
- 3.5.3. Reimbursement Scenarios
- 3.5.4. Market Access
- 3.5.5. Supply Chain
- 3.5.6. Industry Consolidation
- 3.5.7. Pandemic / Unforeseen Disruptions Impact
- 3.6. Key Market Segmentation
- 3.7. Robust Quality Control
- 3.8. Limitations
- 4. Economic And Other Project Specific Considerations
- 4.1. Chapter Overview
- 4.2. Market Dynamics
- 4.2.1. Time Period
- 4.2.1.1. Historical Trends
- 4.2.1.2. Current And Forecasted Estimates
- 4.2.2. Currency Coverage
- 4.2.2.1. Overview Of Major Currencies Affecting The Market
- 4.2.2.2. Impact Of Currency Fluctuations On The Industry
- 4.2.3. Foreign Exchange Impact
- 4.2.3.1. Evaluation Of Foreign Exchange Rates And Their Impact On Market
- 4.2.3.2. Strategies For Mitigating Foreign Exchange Risk
- 4.2.4. Recession
- 4.2.4.1. Historical Analysis Of Past Recessions And Lessons Learnt
- 4.2.4.2. Assessment Of Current Economic Conditions And Potential Impact On The Market
- 4.2.5. Inflation
- 4.2.5.1. Measurement And Analysis Of Inflationary Pressures In The Economy
- 4.2.5.2. Potential Impact Of Inflation On The Market Evolution
- 5. Executive Summary
- 6. Introduction
- 6.1. Chapter Overview
- 6.2. Historical Evolution Of Organ-on-chips
- 6.3. Design Of Organ-on-chips
- 6.4. Classification Of Organ-on-chips
- 6.4.1. Single Organ Chips
- 6.4.2. Disease / Therapeutic Specific Chips
- 6.4.3. Multi Organ Chips
- 6.5. Advantages And Limitations Of Organ-on-chips
- 6.6. Applications Of Organ-on-chips
- 6.7. Future Perspectives
- 7. Market Landscape: Organ-on-chip Technologies And Models
- 7.1. Chapter Overview
- 7.2. Organ-on-chip Technologies And Models Market: Overall Market Landscape
- 7.2.1. Analysis By Type Of Model
- 7.2.2. Analysis By Compatible Organ
- 7.2.3. Analysis By Application Area
- 7.3. Organ-on-chip Technology And Models Market: Developer Landscape
- 7.3.1. Analysis By Year Of Establishment
- 7.3.2. Analysis By Company Size
- 7.3.3. Analysis By Location Of Headquarters
- 7.3.4. Analysis By Leading Technology Providers
- 8. Market Landscape: Organ-on-chips And Plates
- 8.1. Chapter Overview
- 8.2. Organ-on-chips And Plates Market: Overall Market Landscape
- 8.2.1. Analysis By Type Of Model
- 8.2.2. Analysis By Type Of Product
- 8.2.3. Analysis By Compatible Organ
- 8.2.4. Analysis By Application Area
- 8.2.5. Analysis By Material Of Construction
- 8.2.6. Analysis By Type Of Polymer
- 8.2.7. Analysis By Status Of Development
- 8.3. Organ-on-chips And Plates Market: Developer Landscape
- 8.3.1. Analysis By Year Of Establishment
- 8.3.2. Analysis By Company Size
- 8.3.3. Analysis By Location Of Headquarters
- 8.3.4. Analysis By Leading Organ-on-chips And Plates Providers
- 9. Organ-on-chip Providers: Company Profiles Of Players Based In North America
- 9.1. Chapter Overview
- 9.2. Emulate
- 9.2.1. Company Overview
- 9.2.2. Technology Portfolio
- 9.2.3. Product Portfolio
- 9.2.4. Recent Developments And Future Outlook
- 9.3. Synvivo
- 9.4. Draper
- 9.5. Hesperos
- 9.6. Xona Microfluidics
- 10. Organ-on-chip Providers: Company Profiles Of Players Based In Europe
- 10.1. Chapter Overview
- 10.2. Cn Bio
- 10.2.1. Company Overview
- 10.2.2. Technology Portfolio
- 10.2.3. Product Portfolio
- 10.2.4. Recent Developments And Future Outlook
- 10.3. Dynamic42
- 10.4. Insphero
- 10.5. Beonchip
- 10.6. Biomimx
- 10.7. Mimetas
- 10.8. Netri
- 10.9. React4life
- 10.10. Tissuse
- 11. Organ-on-chip Providers: Company Profiles Of Players Based In Asia-pacific
- 11.1. Chapter Overview
- 11.2. Aim Biotech
- 12. Patent Analysis
- 12.1. Chapter Overview
- 12.2. Scope And Methodology
- 12.3. Organ-on-chip: Patent Analysis
- 12.3.1. Analysis By Type Of Patent
- 12.3.2. Analysis By Patent Publication Year
- 12.3.3. Analysis By Patent Application Year
- 12.3.4. Analysis Of Granted Patents By Publication Year
- 12.3.5. Analysis Of Patent Applications By Publication Year
- 12.3.6. Analysis By Patent Jurisdiction
- 12.3.7. Analysis By Cpc Symbols
- 12.3.8. Analysis By Type Of Applicant
- 12.3.9. Analysis By Patent Age
- 12.3.10. Leading Inventors: Analysis By Number Of Patents
- 12.3.11. Leading Industry Players: Analysis By Number Of Patents
- 12.3.12. Leading Non-industry Players: Analysis By Number Of Patents
- 12.4. Patent Benchmarking Analysis
- 12.4.1. Analysis Of Patent Characteristics (Cpc Codes) By Leading Industry Players
- 12.5. Analysis By Patent Valuation
- 12.6. Leading Patents By Number Of Citations
- 13. Brand Positioning Analysis: Organ-on-chip Technologies And Models Providers
- 13.1. Chapter Overview
- 13.2. Methodology
- 13.3. Key Parameters
- 13.4. Organ-on-chip Technologies And Models Providers: Brand Positioning Framework
- 13.4.1. Brand Positioning Matrix: Biomimx
- 13.4.2. Brand Positioning Matrix: Hesperos
- 13.4.3. Brand Positioning Matrix: Emulate
- 13.4.4. Brand Positioning Matrix: Dynamic42
- 13.4.5. Brand Positioning Matrix: React4life
- 13.4.6. Brand Positioning Matrix: Synvivo
- 14. Brand Positioning Analysis: Organ-on-chips And Plates Providers
- 14.1. Chapter Overview
- 14.2. Methodology
- 14.3. Key Parameters
- 14.4. Organ-on-chips And Plates Providers: Brand Positioning Framework
- 14.4.1. Brand Positioning Matrix: Netri
- 14.4.2. Brand Positioning Matrix: Tissuse
- 14.4.3. Brand Positioning Matrix: Aim Biotech
- 14.4.4. Brand Positioning Matrix: Beonchip
- 14.4.5. Brand Positioning Matrix: Cn Bio
- 14.4.6. Brand Positioning Matrix: Insphero
- 14.4.7. Brand Positioning Matrix: Mimetas
- 14.4.8. Brand Positioning Matrix: Synvivo
- 14.4.9. Brand Positioning Matrix: Xona Microfluidics
- 15. Academic Grants Analysis
- 15.1 Chapter Overview
- 15.2. Scope And Methodology
- 15.3. Organ-on-chip: Academic Grants Analysis
- 15.3.1. Analysis By Year Of Grant Award
- 15.3.2. Analysis By Amount Awarded
- 15.3.3. Analysis By Administering Institute Center
- 15.3.4. Analysis By Support Period
- 15.3.5. Analysis By Administering Institute Center And Support Period
- 15.3.6. Analysis By Administering Institute Center And Amount Awarded
- 15.3.7. Analysis By Type Of Grant Application
- 15.3.8. Analysis By Purpose Of Grant
- 15.3.9. Analysis By Activity Code
- 15.3.10. Word Cloud Analysis: Emerging Focus Area
- 15.3.11. Analysis By Study Section Involved
- 15.3.12. Popular Nih Departments: Analysis By Number Of Grants
- 15.3.13. Analysis By Type Of Recipient Organizations
- 15.3.14. Analysis By Support Period And Amount Awarded
- 15.3.15. Popular Recipient Organizations: Analysis By Number Of Grants
- 15.3.16. Popular Recipient Organizations: Analysis By Amount Awarded
- 15.3.17. Analysis By Location Of Recipient Organization
- 16. Partnerships And Collaborations
- 16.1. Chapter Overview
- 16.2. Partnership Models
- 16.3. Organ-on-chip: Partnerships And Collaborations Analysis
- 16.3.1. Analysis By Year Of Partnership
- 16.3.2. Analysis By Type Of Partnership
- 16.3.3. Analysis By Year And Type Of Partnership
- 16.3.4. Analysis By Type Of Organ
- 16.3.5. Analysis By Type Of Partner
- 16.3.6. Analysis By Geography
- 16.3.6.1. Local And International Agreements
- 16.3.6.2. Intercontinental And Intracontinental Agreements
- 16.3.7. Most Active Players: Analysis By Number Of Partnerships
- 17. Funding And Investment Analysis
- 17.1. Chapter Overview
- 17.2. Funding Models
- 17.3. Organ-on-chip: Funding And Investments Analysis
- 17.3.1. Analysis By Year Of Funding
- 17.3.2. Analysis By Type Of Funding
- 17.3.3. Analysis By Year And Type Of Funding
- 17.3.4. Analysis By Amount Invested
- 17.3.5. Analysis By Type Of Funding And Amount Invested
- 17.3.6. Analysis By Purpose Of Funding
- 17.3.7. Analysis By Associated Organ / System
- 17.3.8. Analysis By Therapeutic Area
- 17.3.9. Analysis By Geography
- 17.3.10. Most Active Players: Analysis By Number Of Funding Instances
- 17.3.11. Most Active Players: Analysis By Amount Raised
- 17.3.12. Leading Investors: Analysis By Number Of Funding Instances
- 17.4. Concluding Remarks
- 18. Case Study: Scaffold-free 3d Cell Culture Systems
- 18.1. Chapter Overview
- 18.2. Scaffold-free Products: Overall Market Landscape
- 18.2.1. Analysis By Status Of Development
- 18.2.2. Analysis By Type Of System
- 18.2.3. Analysis By Type Of Product
- 18.2.4. Analysis By Material Used For Construction
- 18.2.5. Analysis By Type Of System And Material Used For Construction
- 18.3. Scaffold-free Products: Developer Landscape
- 18.3.1. Analysis By Year Of Establishment
- 18.3.2. Analysis By Company Size
- 18.3.3. Analysis By Location Of Headquarters
- 19. Market Impact Analysis: Drivers, Restraints, Opportunities And Challenges
- 19.1. Chapter Overview
- 19.2. Market Drivers
- 19.3. Market Restraints
- 19.4. Market Opportunities
- 19.5. Market Challenges
- 19.6. Conclusion
- 20. Global Organ-on-chip Market
- 20.1. Chapter Overview
- 20.2. Key Assumptions And Methodology
- 20.3. Organ-on-chip Market: Historical Trends (Since 2019) And Forecasted Estimates (Till 2035)
- 20.3.1. Scenario Analysis
- 20.3.1.1. Conservative Scenario
- 20.3.1.2. Optimistic Scenario
- 20.4. Key Market Segmentations
- 20.5. Leading Industry Players
- 21. Organ-on-chip Market, By Type Of Product
- 21.1. Chapter Overview
- 21.2. Key Assumptions And Methodology
- 21.3. Organ-on-chip Market: Distribution By Type Of Product
- 21.3.1. Organ-on-chip Market For Organ Based Models: Historical Trends (Since 2019) And Forecasted Estimates (Till 2035)
- 21.3.2. Organ-on-chip Market For Disease Based Models: Historical Trends (Since 2019) And Forecasted Estimates (Till 2035)
- 21.4. Data Triangulation And Validation
- 22. Organ-on-chip Market, By Type Of Organ
- 22.1. Chapter Overview
- 22.2. Key Assumptions And Methodology
- 22.3. Organ-on-chip Market: Distribution By Type Of Organ
- 22.3.1. Organ-on-chip Market For Single Organ Based Models: Historical Trends (Since 2019) And Forecasted Estimates (Till 2035)
- 22.3.2. Organ-on-chip Market For Multi Organ Based Models: Historical Trends (Since 2019) And Forecasted Estimates (Till 2035)
- 22.4. Data Triangulation And Validation
- 23. Organ-on-chip Market, By Type Of Single Organ Based Model
- 23.1. Chapter Overview
- 23.2. Key Assumptions And Methodology
- 23.3. Organ-on-chip Market: Distribution By Type Of Single Organ Based Model
- 23.3.1. Organ-on-chip Market For Liver Models: Historical Trends (Since 2019) And Forecasted Estimates (Till 2035)
- 23.3.2. Organ-on-chip Market For Lung Models: Historical Trends (Since 2019) And Forecasted Estimates (Till 2035)
- 23.3.3. Organ-on-chip Market For Brain Models: Historical Trends (Since 2019) And Forecasted Estimates (Till 2035)
- 23.3.4. Organ-on-chip Market For Heart Models: Historical Trends (Since 2019) And Forecasted Estimates (Till 2035)
- 23.3.5. Organ-on-chip Market For Intestine Models: Historical Trends (Since 2019) And Forecasted Estimates (Till 2035)
- 23.3.6. Organ-on-chip Market For Kidney Models: Historical Trends (Since 2019) And Forecasted Estimates (Till 2035)
- 23.3.7. Organ-on-chip Market For Other Organ Based Models: Historical Trends (Since 2019) And Forecasted Estimates (Till 2035)
- 23.4. Data Triangulation And Validation
- 24. Organ-on-chip Market, By Type Of Material
- 24.1. Chapter Overview
- 24.2. Key Assumptions And Methodology
- 24.3. Organ-on-chip Market: Distribution By Type Of Material
- 24.3.1. Organ-on-chip Market For Polydimethylsiloxane Based Models: Historical Trends (Since 2019) And Forecasted Estimates (Till 2035)
- 24.3.2. Organ-on-chip Market For Other Polymer Based Models: Historical Trends (Since 2019) And Forecasted Estimates (Till 2035)
- 24.3.3. Organ-on-chip Market For Glass Based Models: Historical Trends (Since 2019) And Forecasted Estimates (Till 2035)
- 24.3.4. Organ-on-chip Market For Other Material Based Models: Historical Trends (Since 2019) And Forecasted Estimates (Till 2035)
- 24.4. Data Triangulation And Validation
- 25. Organ-on-chip Market, By Purpose
- 25.1. Chapter Overview
- 25.2. Key Assumptions And Methodology
- 25.3. Organ-on-chip Market: Distribution By Purpose
- 25.3.1. Organ-on-chip Market For Research Purposes: Historical Trends (Since 2019) And Forecasted Estimates (Till 2035)
- 25.3.2. Organ-on-chip Market For Therapeutic Purposes: Historical Trends (Since 2019) And Forecasted Estimates (Till 2035)
- 25.4. Data Triangulation And Validation
- 26. Organ-on-chip Market, By Application Area
- 26.1. Chapter Overview
- 26.2. Key Assumptions And Methodology
- 26.3. Organ-on-chip Market: Distribution By Application Area
- 26.3.1. Organ-on-chip Market For Drug Discovery And Toxicity Testing: Historical Trends (Since 2019) And Forecasted Estimates (Till 2035)
- 26.3.2. Organ-on-chip Market For Cancer Research: Historical Trends (Since 2019) And Forecasted Estimates (Till 2035)
- 26.3.3. Organ-on-chip Market For Stem Cell Research: Historical Trends (Since 2019) And Forecasted Estimates (Till 2035)
- 26.3.4. Organ-on-chip Market For Tissue Engineering And Regenerative Medicine: Historical Trends (Since 2019) And Forecasted Estimates (Till 2035)
- 26.4. Data Triangulation And Validation
- 27. Organ-on-chip Market, By End User
- 27.1. Chapter Overview
- 27.2. Key Assumptions And Methodology
- 27.3. Organ-on-chip Market: Distribution By End User
- 27.3.1. Organ-on-chip Market For Pharmaceutical And Biotech Companies: Historical Trends (Since 2019) And Forecasted Estimates (Till 2035)
- 27.3.2. Organ-on-chip Market For Academic And Research Institutes: Historical Trends (Since 2019) And Forecasted Estimates (Till 2035)
- 27.3.3. Organ-on-chip Market For Cosmetic Industry Players: Historical Trends (Since 2019) And Forecasted Estimates (Till 2035)
- 27.3.4. Organ-on-chip Market For Other End Users: Historical Trends (Since 2019) And Forecasted Estimates (Till 2035)
- 27.4. Data Triangulation And Validation
- 28. Organ-on-chip Market, By Geographical Regions
- 28.1. Chapter Overview
- 28.2. Key Assumptions And Methodology
- 28.3. Organ-on-chip Market: Distribution By Geographical Regions
- 28.3.1. Organ-on-chip Market In North America: Historical Trends (Since 2019) And Forecasted Estimates (Till 2035)
- 28.3.1.1. Organ-on-chip Market In The Us: Historical Trends (Since 2019) And Forecasted Estimates (Till 2035)
- 28.3.1.2. Organ-on-chip Market In Canada: Historical Trends (Since 2019) And Forecasted Estimates (Till 2035)
- 28.3.1.3. Organ-on-chip Market For Rest Of North America: Historical Trends (Since 2019) And Forecasted Estimates (Till 2035)
- 28.3.2. Organ-on-chip Market In Europe: Historical Trends (Since 2019) And Forecasted Estimates (Till 2035)
- 28.3.2.1. Organ-on-chip Market In The Uk: Historical Trends (Since 2019) And Forecasted Estimates (Till 2035)
- 28.3.2.2. Organ-on-chip Market In Germany: Historical Trends (Since 2019) And Forecasted Estimates (Till 2035)
- 28.3.2.3. Organ-on-chip Market In France: Historical Trends (Since 2019) And Forecasted Estimates (Till 2035)
- 28.3.2.4. Organ-on-chip Market In Italy: Historical Trends (Since 2019) And Forecasted Estimates (Till 2035)
- 28.3.2.5. Organ-on-chip Market In Spain: Historical Trends (Since 2019) And Forecasted Estimates (Till 2035)
- 28.3.2.6. Organ-on-chip Market For Rest Of Europe: Historical Trends (Since 2019) And Forecasted Estimates (Till 2035)
- 28.3.3. Organ-on-chip Market In Asia-pacific: Historical Trends (Since 2019) And Forecasted Estimates (Till 2035)
- 28.3.3.1. Organ-on-chip Market In China: Historical Trends (Since 2019) And Forecasted Estimates (Till 2035)
- 28.3.3.2. Organ-on-chip Market In Japan: Historical Trends (Since 2019) And Forecasted Estimates (Till 2035)
- 28.3.3.3. Organ-on-chip Market In South Korea: Historical Trends (Since 2019) And Forecasted Estimates (Till 2035)
- 28.3.3.4. Organ-on-chip Market In Australia: Historical Trends (Since 2019) And Forecasted Estimates (Till 2035)
- 28.3.3.5. Organ-on-chip Market For Rest Of Asia-pacific: Historical Trends (Since 2019) And Forecasted Estimates (Till 2035)
- 28.3.4. Organ-on-chip Market For Latin America: Historical Trends (Since 2019) And Forecasted Estimates (Till 2035)
- 28.3.5. Organ-on-chip Market For Middle East And North Africa: Historical Trends (Since 2019) And Forecasted Estimates (Till 2035)
- 28.4. Data Triangulation And Validation
- 29. Conclusion
- 30. Executive Insights
- 30.1. Chapter Overview
- 30.2. Company A
- 30.2.1. Company Snapshot
- 30.2.2. Interview Transcript: Chief Executive Officer
- 30.3. Company B
- 30.3.1. Company Snapshot
- 30.3.2. Interview Transcript: Chief Executive Officer
- 30.4. Company C
- 30.4.1. Company Snapshot
- 30.4.2. Interview Transcript: Chief Technology Officer
- 30.5. Company D
- 30.5.1. Company Snapshot
- 30.5.2. Interview Transcript: Chief Executive Officer
- 30.6. Company E
- 30.6.1. Company Snapshot
- 30.6.2. Interview Transcript: Chief Executive Officer
- 30.7. Company F
- 30.7.1. Company Snapshot
- 30.7.2. Interview Transcript: Chief Executive Officer
- 30.8. Company G
- 30.8.1. Company Snapshot
- 30.8.2. Interview Transcript: Chief Business Development Officer
- 30.9. Company H
- 30.9.1. Company Snapshot
- 30.9.2. Interview Transcript: President
- 31. Appendix 1: Tabulated Data
- 32. Appendix 2: List Of Companies And Organizations
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
